drugset / Trial / NCT00236379

A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder

NCT00236379 ↗

Phase 4 Completed 59 enrolled Janssen, LP
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess and compare how risperidone and olanzapine, two antipsychotic medications, affect the regulation of glucose (sugar) in the body.

Timeline

Start
—
Primary completion
—
Completion
2003-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Olanzapine Small molecule 20 mg Oral
Subject Risperidone Other / unclassified 6 mg Oral